Retrospective analysis predicts molecular biomarkers in glioma using multiparametric PET/MRI, suggesting improved diagnostic accuracy.
Motivation: There are few studies on the prediction of multiple genotype status in glioma by method of multiparameter 18F-FET PET/MR radiomics. Goal(s): To explore the value of radiomics features based on multiparametric O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET/MRI in predicting the molecular biomarker status of glioma. Approach: Retrospective radiomics analysis of 97 glioma patients' multiparametric PET/MRI data, employing Bayesian modeling and Receiver Operating Characteristic (ROC) curves to assess predictive performance for IDH, TERTp, and MGMT status. Results: Multi-modal radiomics models demonstrated superior performance in the testing cohorts (IDH AUC=0.97, TERTp AUC=0.86, MGMT AUC=0.90) compared to single-modal models across all types of molecular biomarkers. Impact: The radiomics models, which incorporate structural, proliferative, and metabolic information based on multiparameter 18F-FET PET/MRI, demonstrated effective predictive performance for the molecular biomarker status of glioma and had the potential to optimize diagnostic processes.
No takes yet. Share an insight, caveat, or question.
Jie Bai (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: